Friday, May 25, 2018
THC and CBD Not Associated With Impaired Driving, States Study
The administration of THC and CBD is not associated with either driving impairment or an increased risk of motor vehicle accident, according to a study published in the journal Brain and Behavior.
Norwegian and Spanish researchers reviewed the results from several driving performance studies that assessed subjects’ abilities following the use of THC:CBD oromucosal spray.
“Real-world registries did not show any evidence of an increase in motor vehicle accidents associated with THC:CBD oromucosal spray,” they reported. “The majority of patients reported an improvement in driving ability after starting THC:CBD oromucosal spray.” The spray, marketed in several countries throughout the world as the prescription drug Sativex, relieves spasticity in patients with multiple sclerosis.
Authors concluded, “THC:CBD oromucosal spray was shown not to impair driving performance.”
The post THC and CBD Not Associated With Impaired Driving, States Study appeared first on The Marijuana Herald.